Clinical and molecular prognostic factors in operable laryngeal cancer

  • Konstantinos Vlachtsis
  • Angelos Nikolaou
  • Konstantinos Markou
  • George Fountzilas
  • Ioannis Daniilidis
Head and Neck Oncology


Many factors affect the prognosis in operable laryngeal squamous cell carcinoma (LSCC). Many clinical factors have been implicated in tumor recurrence and poor survival of the patients. The aim of the present study is to investigate the demographic, clinical and histological characteristics as prognostic factors. Moreover, our aim is to analyze the role of modern molecular biomarkers in the prognosis of patients with LSCC. One hundred patients with operable laryngeal carcinoma underwent surgery as primary treatment between April 1999 and April 2002. Ninety-four of them were men and 6 women, with a median age of 62 years (39–77). All demographic data of the patients were recorded. Staging of the tumor revealed 20 cases with T2 cancer, 46 cases with T3 and 34 cases with T4, while N classification included 91 patients with N0 tumor, 3 with N1 and 6 with N2. Among the 100 cases, 47 were located in the glottis, 46 in the supraglottic region and 7 were transglottic. Histology grading revealed 35 cases of grade G1, 50 cases of G2 and 15 cases of G3. Postoperatively, all patients were followed regularly for the possibility of tumor relapse, with a median follow-up period of 40.2 months (4.8–58.4). During the operation, a tissue specimen was collected from the tumor. The specimens were used for RNA and DNA extraction. Isolated RNA was used to investigate the expression of wt-p53, bcl-2, VEGF and EGFR by the reverse transcriptase PCR method (RT-PCR) using specific primers, while genomic DNA was used for the detection of EBV and HPV (16/18 subtypes) by the consensus primer-mediated polymerase chain reaction method (PCR). All data such as tumor recurrence and survival were recorded. Statistical analysis was performed using the SPSS and STATA statistical packages in order to investigate the role of all clinical and molecular factors and their combinations as significant prognostic markers. The tumor recurrence rate was 31%, while the tumor associated death rate was 27% and total death rate 30%. Univariate analysis for overall survival showed significance for the T stage, TNM stage and site of the tumor. Univariate analysis for the time to progression showed significance for the T stage, N stage, TNM stage, site of the tumor and tumors simultaneously positive for EGFR and VEGF, while EGFR expression was borderline insignificant. Multivariate analysis revealed TNM stage as the only significant factor for overall survival, and TNM stage, site of the tumor and EGFR expression as significant factors for time to progression. The molecular biomarkers EGFR and VEGF have a prognostic significance in laryngeal cancer in addition to the established clinical prognostic factors such as the stage and site of the tumor. These markers, apart from their role in carcinogenesis, seem to play an important role in tumor relapse.


Laryngeal cancer Prognostic factors p-53 bcl-2 EGFR VEGF HPV EBV 


  1. 1.
    Aaltonen L M, Rihkanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112:700–707CrossRefPubMedGoogle Scholar
  2. 2.
    Almadori G, Cadoni G, Galli J, Ferrandina G, Scambia G, Exarchakos G, Paludetti G, Ottaviani F (1999) Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor. Int J Cancer 84:188–191PubMedGoogle Scholar
  3. 3.
    Assimakopoulos D, Kolettas E, Zagorianakou N, Evangelou A, Skevas A, Agnantis NJ (2000) Prognostic significance of p53 in the cancer of the larynx. Anticancer Res 20:3555–3564Google Scholar
  4. 4.
    Barra S, Barzan L, Maione A, Cadelano A, Pin M, Franceschi S, Comoretto R (1994) Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Laryngoscope 104:95–98Google Scholar
  5. 5.
    Baselga J, Hammond LA (2002) HER-targeted tyrosine-kinase inhibitors. Oncology 63 [Suppl 1]:6–16Google Scholar
  6. 6.
    Boffeta P, Merletti F, Faggiano F, Migliaretti G, Ferro G, Zanetti R, Terracini B (1997) Prognostic factors and survival of laryngeal cancer patients from Turin, Italy. A population-based study. Am J Epidemiol 145:1100–1105Google Scholar
  7. 7.
    Brasilino de Carvalho M (1998) Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 20:16–21CrossRefPubMedGoogle Scholar
  8. 8.
    Bryne M, Jenssen N, Boysen M (1995) Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 427:277–281Google Scholar
  9. 9.
    Capone R, Pai S, Koch W, et al (2000) Detection and quantification of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 6:4171–4175Google Scholar
  10. 10.
    Carrillo JF, Frias-Mendivil M, Lopez-Graniel C, Beitia AI, Ochoa-Carrillo FJ (1999) The impact of preoperative tracheotomy on T3 transglottic carcinomas of the larynx. Eur Arch Otorhinolaryngol 256:78–82Google Scholar
  11. 11.
    Codd JD, Salisbury JR, Packham G, Nicholson LJ (1999) A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol 187:549–555Google Scholar
  12. 12.
    Danic D, Maruic M, Uzarevic B, Milicic D (2000) Prognostic factors in squamous cell carcinoma of the larynx. ORL J Otorhinolaryngol Relat Spec 62:143–148Google Scholar
  13. 13.
    Eiband JD, Elias EG, Suter CM, Gray WC, Didolkar MS (1989) Prognostic factors in squamous cell carcinoma of the larynx. Am J Surg 158:314–317Google Scholar
  14. 14.
    Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345:1890–1900CrossRefPubMedGoogle Scholar
  15. 15.
    Ford AC, Grandis JR (2003) Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 25:67–73Google Scholar
  16. 16.
    Geisler S, Olsham A, Weissler M, et al (2002) p16 and p53 expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 8:3445–3453Google Scholar
  17. 17.
    Hardisson D (2003) Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260:502–508Google Scholar
  18. 18.
    Hirvikoski P, Kumpulainen E, Virtaniemi J, Pirinen R, Salmi L, Halonen P, Johansson R, Kosma VM (1999) Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Eur J Cancer 35:231–237Google Scholar
  19. 19.
    Hotz MA, Bosq J, Zbaeren P, Reed J, Schwab G, Krajewski S, Brousset P, Borner MM (1999) Spontaneous apoptosis and the expression of p53 and bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125:417–422Google Scholar
  20. 20.
    Jackel MC, Dorudian MA, Marx D, Brinck U, Schauer A, Steiner W (1999) Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 85:591–599Google Scholar
  21. 21.
    Jeannon JP, Soames J, Lunec J, Awwad S, Ashton V, Wilson JA (2000) Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal carcer. Clin Otolaryngol 25:23–27Google Scholar
  22. 22.
    Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK (1998) The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 82:2159–2165Google Scholar
  23. 23.
    Kowalski LP, Franco EL, de Andrade Sobrinho J, Oliveira BV, Pontes PL (1991) Prognostic factors in laryngeal cancer patients submitted to surgical treatment. J Surg Oncol 48:87–95Google Scholar
  24. 24.
    Lassaletta L, Garcia-Pallares M, Morera E, Bernaldez R, Gavilan J (2001) T3 glottic cancer: oncologic results and prognostic factors. Otolaryngol Head Neck Surg 124:556–560Google Scholar
  25. 25.
    Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH (2002) Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 22:2089–2096Google Scholar
  26. 26.
    Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO (2002) Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 24:792–799Google Scholar
  27. 27.
    Markou K, Vlachtsis K, Nikolaou A, Petridis D, Kouloulas A, Daniilidis I (2004) Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence? Eur Arch Otorhinolaryngol 261:61–67Google Scholar
  28. 28.
    Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanini ME, Cadoni G, Benedetti-Panici P, Paludetti G, Scambia G, Mancuso S (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74:1253–1257PubMedGoogle Scholar
  29. 29.
    Mielcarek-Kuchta D, Olofsson J, Golusinski W (2003) p53, Ki67 and cyclin D1 as prognostic factors of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 260:549–554Google Scholar
  30. 30.
    Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J (2000) Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 83:775–781Google Scholar
  31. 31.
    Modjtahedi H, Moscatello DK, Box G, Green M, Shotton C, Lamb DJ, Reynolds LJ, Wong AJ, Dean C, Thomas H, Eccles S (2003) Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy. Int J Cancer 105:273–280Google Scholar
  32. 32.
    Morales-Angulo C, Val-Bernal F, Buelta L, Fernandez F, Garcia-Castrillo L, Rama J (1998) Prognostic factors in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg 119:548–553Google Scholar
  33. 33.
    Nakashima T, Wang XF, Masuda M, Inokuchi A, Komiyama S (1999) Overexpression of p53 nuclear protein in premelignant and malignant laryngeal lesions. Eur Arch Otorhinolaryngol 256 [Suppl 1]:S56–59Google Scholar
  34. 34.
    Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP (1998) Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 82:286–291Google Scholar
  35. 35.
    Nathan CA, Sanders K, Abreo FW, Nassar R, Glass J (2000) Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 60:3599–3604Google Scholar
  36. 36.
    Neuchrist C, Quint C, Pammer A, Burian M (1999) Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol 119:732–738Google Scholar
  37. 37.
    Nicolai P, Redaelli de Zinis LO, Tomenzoli D, Barezzani MG, Bertoni F, Bignardi M, Antonelli AR (1997) Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 19:323–334CrossRefPubMedGoogle Scholar
  38. 38.
    O-charoenrat P, Rhys-Evans P, Eccles S (2001) Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma corelates with lymph node metastasis. Cancer 92:556–568Google Scholar
  39. 39.
    Pulkkinen JO, Klemi P, Martikainen P, Grenman R (1999) Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Anticancer Res 19:703–707Google Scholar
  40. 40.
    Ranson M (2002) ZD1839 (Iressa): for more than just non-small cell lung cancer. Oncologist 7 [Suppl 4]:16–24Google Scholar
  41. 41.
    Riedel F, Gotte K, Schwalb J, Bergler W, Hormann K (2000) Expression of 92-kDa type IV collagenase correlates with angiogenesis markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 17:1099–1105Google Scholar
  42. 42.
    Rowley H, Roland NJ, Helliwell TR, Caslin A, Kinsella AR, Jones AS (1998) p53 protein expression in tumours from the head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin Otolaryngol 23:57–62Google Scholar
  43. 43.
    Rubin J, Johnson JT, Myers EN (1990) Stomal recurrence after laryngectomy: interrelated risk factor study. Otolaryngol Head Neck Surg 103:805–812Google Scholar
  44. 44.
    Sittel C, Ecke HE, Damm M, von Pritzbuer E, Kvasnicka HM (2000) Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 110:1012–1017Google Scholar
  45. 45.
    Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA (2001) Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of larynx and hypopharynx. Laryngoscope 111:1079–1087Google Scholar
  46. 46.
    Stankiewicz C (1994) Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 251:418–422Google Scholar
  47. 47.
    Takes RP, Baatenburg de Jong RJ, Scuuring E, Hermans J, Vis AA, Litvinov SV, van Krieken JH (2002) Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123:412–419Google Scholar
  48. 48.
    Weber A, Tannapfel A (2002) Prognosefactoren bei Kopf-Hals-karzinomen. HNO 50:35–42CrossRefPubMedGoogle Scholar
  49. 49.
    Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ (1995) Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 104:503–510Google Scholar
  50. 50.
    Yang HJ, Cho YJ, Kim HS, Chang MS, Sung MW, Kim WH (2001) Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck. Head Neck 23:629–636Google Scholar
  51. 51.
    Yilmaz T, Hosal AS, Gedikoglu G, Onerci M, Gursel B (1998) Prognostic significance of vascular and perineural invation in cancer of the larynx. Am J Otolaryngol 19:83–88Google Scholar
  52. 52.
    Yilmaz T, Hosal S, Gedikoglou G, Turan E, Ayas K (1998) Prognostic significance of depth of invasion in cancer of the larynx. Laryngoscope 108:764–768Google Scholar
  53. 53.
    Yuen AP, Wei WI, Ho WK, Hui Y (1996) Risk factors of tracheostomal recurrence after laryngectomy for laryngeal carcinoma. Am J Surg 172:263–266Google Scholar
  54. 54.
    Yuen PW, Lam KY, Choy JT, Ho WT, Wei WI (2000) Clinicopathological significance of p53 and p21 expression in the surgical treatment of laryngeal carcinoma. Anticancer Res 20:4863–4866Google Scholar
  55. 55.
    Vielba R, Bilbao J, Ispizua A, et al (2003) p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113:167–172Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Konstantinos Vlachtsis
    • 1
  • Angelos Nikolaou
    • 1
  • Konstantinos Markou
    • 1
  • George Fountzilas
    • 2
  • Ioannis Daniilidis
    • 1
  1. 1.Department of Otorhinolaryngology Head and Neck SurgeryAHEPA Hospital, Aristotle University of ThessalonikiThessalonikiGreece
  2. 2.Oncology Unit, First Department of Internal MedicineAHEPA Hospital, Aristotle University of ThessalonikiThessalonikiGreece

Personalised recommendations